conatumumab
oleclumab
panitumumab
mapatumumab
drozitumab
patritumab
lintuzumab
matuzumab
naptumomab estafenatox
tenatumomab
onartuzumab
lexatumumab
inotuzumab
duligotuzumab
sibrotuzumab
dacetuzumab
inotuzumab ozogamicin
tigatuzumab
figitumumab
nofetumomab
dalotuzumab
lucatumumab
pamrevlumab
acrixolimab
adecatumumab
iratumumab
teprotumumab
pritumumab
avelumab
agonistic monoclonal antibody
ocrelizumab
durvalumab
tucotuzumab
elotuzumab
sonepcizumab
samalizumab
brentuximab
apolizumab
carlumab
cergutuzumab
gevokizumab
ravulizumab
pidilizumab
tislelizumab
olaratumab
abagovomab
brolucizumab
glembatumumab
ipilimumab
bivatuzumab